Modulation of inflammatory signaling pathways by phytochemicals in ovarian cancer

Genes and Nutrition

Volumn 6, Issue 2, 2011, Pages 109-115

  Kim, Mi Kyung ^a   Kim, Kidong ^b   Han, Jae Yong ^c   Lim, Jeong Mook ^c   Song, Yong Sang ^a,c  

^a Seoul National University   (South Korea)

^b Korea Cancer Center Hospital   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

Anti inflammation; Chemoprevention; Ovarian cancer; Phytochemicals

Indexed keywords

CELECOXIB; CURCUMIN; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DOCETAXEL; EPIGALLOCATECHIN GALLATE; GENISTEIN; I KAPPA B KINASE; IDRONOXIL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; NONSTEROID ANTIINFLAMMATORY AGENT; PLANT MEDICINAL PRODUCT; RESVERATROL; STAT3 PROTEIN; TRANSCRIPTION FACTOR AP 1;

ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER PREVENTION; CANCER RISK; CARCINOGENESIS; CHRONIC INFLAMMATION; COLON CANCER; COLORECTAL ADENOMA; DISEASE ASSOCIATION; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; DRUG SAFETY; DRUG TARGETING; HUMAN; IMMUNOMODULATION; LUNG METASTASIS; NONHUMAN; OVARY CANCER; PHYTOCHEMISTRY; PROTEIN FUNCTION; REVIEW; RISK REDUCTION; SIGNAL TRANSDUCTION; SKIN CANCER; TRANSCRIPTION INITIATION;

EID: 79956347718     PISSN: 15558932     EISSN: 18653499     Source Type: Journal    
DOI: 10.1007/s12263-011-0209-y     Document Type: Review

References (68)

1. VM Adhami A Malik N Zaman S Sarfaraz IA Siddiqui DN Syed F Afaq FS Pasha M Saleem H Mukhtar 2007 Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo Clin Cancer Res 13 5 1611 1619 17332308 10.1158/1078-0432.CCR-06-2269 1:CAS:528:DC%2BD2sXitlSjtb4%3D (Pubitemid 46450454)
2. BB Aggarwal A Bhardwaj RS Aggarwal NP Seeram S Shishodia Y Takada 2004 Role of resveratrol in prevention and therapy of cancer: Preclinical and clinical studies Anticancer Res 24 5A 2783 2840 15517885 1:CAS:528: DC%2BD2cXhtVSjsLrK (Pubitemid 39409568)
3. BB Aggarwal S Shishodia Y Takada S Banerjee RA Newman CE Bueso-Ramos JE Price 2005 Curcumin suppresses the paclitaxel-induced nuclear factor-kappab pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice Clin Cancer Res 11 20 7490 7498 16243823 10.1158/1078-0432.CCR-05-1192 1:CAS:528:DC%2BD2MXhtFartbjM (Pubitemid 41507710)
4. MA Altinoz R Korkmaz 2004 Nf-kappab, macrophage migration inhibitory factor and cyclooxygenase-inhibitions as likely mechanisms behind the acetaminophen- and nsaid-prevention of the ovarian cancer Neoplasma 51 4 239 247 15254653 1:CAS:528:DC%2BD2cXms1Gqs7w%3D (Pubitemid 38915539)
5. AR Amin O Kucuk FR Khuri DM Shin 2009 Perspectives for cancer prevention with natural compounds J Clin Oncol 27 16 2712 2725 19414669 10.1200/JCO.2008.20.6235
6. N Arber CJ Eagle J Spicak I Racz P Dite J Hajer M Zavoral MJ Lechuga P Gerletti J Tang RB Rosenstein K Macdonald P Bhadra R Fowler J Wittes AG Zauber SD Solomon B Levin 2006 Celecoxib for the prevention of colorectal adenomatous polyps New Engl J Med 355 9 885 895 16943401 10.1056/NEJMoa061652 1:CAS:528:DC%2BD28XovFehurc%3D (Pubitemid 44315981)
7. AC Bharti N Donato S Singh BB Aggarwal 2003 Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa b and ikappabalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis Blood 101 3 1053 1062 12393461 10.1182/blood-2002-05-1320 1:CAS:528:DC%2BD3sXptVCisg%3D%3D (Pubitemid 36139379)
8. Z Cao J Fang C Xia X Shi BH Jiang 2004 Trans-3, 4, 5′- trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells Clin Cancer Res 10 15 5253 5263 15297429 10.1158/1078-0432.CCR-03-0588 1:CAS:528: DC%2BD2cXmtlSiu7Y%3D (Pubitemid 39099800)
9. MM Chan D Fong KJ Soprano WF Holmes H Heverling 2003 Inhibition of growth and sensitization to cisplatin-mediated killing of ovarian cancer cells by polyphenolic chemopreventive agents J Cell Physiol 194 1 63 70 12447990 10.1002/jcp.10186 1:CAS:528:DC%2BD38XptlGqsL8%3D (Pubitemid 35424228)
10. MM Chan HI Huang MR Fenton D Fong 1998 In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties Biochem Pharmacol 55 12 1955 1962 9714315 10.1016/S0006-2952(98)00114-2 1:CAS:528:DyaK1cXksVWjtrc%3D (Pubitemid 28477465)
11. JW Cho KS Lee CW Kim 2007 Curcumin attenuates the expression of il-1beta, il-6, and tnf-alpha as well as cyclin e in tnf-alpha-treated hacat cells; nf-kappab and mapks as potential upstream targets Int J Mol Med 19 3 469 474 17273796 1:CAS:528:DC%2BD2sXivVOnsb0%3D
12. EJ Choi T Kim MS Lee 2007 Pro-apoptotic effect and cytotoxicity of genistein and genistin in human ovarian cancer sk-ov-3 cells Life sci 80 15 1403 1408 17291540 10.1016/j.lfs.2006.12.031 1:CAS:528:DC%2BD2sXislKgt7s%3D (Pubitemid 46367066)
13. AH Conney T Lysz T Ferraro TF Abidi PS Manchand JD Laskin MT Huang 1991 Inhibitory effect of curcumin and some related dietary compounds on tumor promotion and arachidonic acid metabolism in mouse skin Adv Enzym Regulat 31 385 396 10.1016/0065-2571(91)90025-H 1:CAS:528:DyaK38XlsVaqtrs%3D
14. DW Cramer BL Harlow L Titus-Ernstoff K Bohlke WR Welch ER Greenberg 1998 Over-the-counter analgesics and risk of ovarian cancer Lancet 351 9096 104 107 9439495 10.1016/S0140-6736(97)08064-1 1:STN:280:DyaK1c7gt1Klug%3D%3D (Pubitemid 28026637)
15. N Dhillon BB Aggarwal RA Newman RA Wolff AB Kunnumakkara JL Abbruzzese CS Ng V Badmaev R Kurzrock 2008 Phase ii trial of curcumin in patients with advanced pancreatic cancer Clin Cancer Res 14 14 4491 4499 18628464 10.1158/1078-0432.CCR-08-0024 1:CAS:528:DC%2BD1cXosFGitLw%3D
16. N Dijsselbloem W Vanden Berghe A De Naeyer G Haegeman 2004 Soy isoflavone phyto-pharmaceuticals in interleukin-6 affections. Multi-purpose nutraceuticals at the crossroad of hormone replacement, anti-cancer and anti-inflammatory therapy Biochem Pharmacol 68 6 1171 1185 15313415 10.1016/j.bcp.2004.05.036 1:CAS:528:DC%2BD2cXmslOns7s%3D (Pubitemid 39094283)
17. MF Fathalla 1971 Incessant ovulation-a factor in ovarian neoplasia? Lancet 2 7716 163 4104488 10.1016/S0140-6736(71)92335-X 1:STN:280: DyaE3M3ls12ltw%3D%3D
18. JR Gamble P Xia CN Hahn JJ Drew CJ Drogemuller D Brown MA Vadas 2006 Phenoxodiol, an experimental anticancer drug, shows potent antiangiogenic properties in addition to its antitumour effects Int J Cancer 118 10 2412 2420 16353157 10.1002/ijc.21682 1:CAS:528:DC%2BD28XktlGiur4%3D
19. A Goel AB Kunnumakkara BB Aggarwal 2008 Curcumin as "Curecumin" : from kitchen to clinic Biochem Pharmacol 75 4 787 809 17900536 10.1016/j.bcp.2007.08.016 1:CAS:528:DC%2BD1cXhsFymtLY%3D (Pubitemid 351181424)
20. G Gossner M Choi L Tan S Fogoros KA Griffith M Kuenker JR Liu 2007 Genistein-induced apoptosis and autophagocytosis in ovarian cancer cells Gynecol Oncol 105 1 23 30 17234261 10.1016/j.ygyno.2006.11.009 1:CAS:528: DC%2BD2sXjsVemsb4%3D (Pubitemid 46441453)
21. SI Grivennikov FR Greten M Karin 2010 Immunity, inflammation, and cancer Cell 140 6 883 899 20303878 10.1016/j.cell.2010.01.025 1:CAS:528: DC%2BC3cXlsVSgu7g%3D
22. L Guo Y Peng J Yao L Sui A Gu J Wang 2010 Anticancer activity and molecular mechanism of resveratrol-bovine serum albumin nanoparticles on subcutaneously implanted human primary ovarian carcinoma cells in nude mice Cancer Biother Radiopharmaceut 25 4 471 477 10.1089/cbr.2009.0724 1:CAS:528:DC%2BC3cXhtVGrsbbI
23. K Hastak S Gupta N Ahmad MK Agarwal ML Agarwal H Mukhtar 2003 Role of p53 and nf-kappab in epigallocatechin-3-gallate-induced apoptosis of lncap cells Oncogene 22 31 4851 4859 12894226 10.1038/sj.onc.1206708 1:CAS:528: DC%2BD3sXlvVKgu7c%3D (Pubitemid 36981273)
24. M Holmes-McNary AS Baldwin Jr 2000 Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the ikappab kinase Cancer Res 60 13 3477 3483 10910059 1:CAS:528:DC%2BD3cXkvFChsL4%3D (Pubitemid 30482167)
25. SW Huh SM Bae YW Kim JM Lee SE Namkoong IP Lee SH Kim CK Kim WS Ahn 2004 Anticancer effects of (-)-epigallocatechin-3-gallate on ovarian carcinoma cell lines Gynecol Oncol 94 3 760 768 15350370 10.1016/j.ygyno.2004.05.031 1:CAS:528:DC%2BD2cXntlOhtb4%3D (Pubitemid 39194472)
26. SP Hussain CC Harris 2007 Inflammation and cancer: An ancient link with novel potentials Int J Cancer 121 11 2373 2380 17893866 10.1002/ijc.23173 1:CAS:528:DC%2BD2sXhtlShtb%2FM (Pubitemid 350022405)
27. A Jemal R Siegel E Ward Y Hao J Xu MJ Thun 2009 Cancer statistics CA: a Cancer J Clin 59 4 225 249 10.3322/caac.20006
28. YT Jeon YS Song 2006 Cyclooxygenases in cancer: chemoprevention and sensitization to conventional therapies Mini Rev Med Chem 6 7 827 833 16842132 10.2174/138955706777698660 1:CAS:528:DC%2BD28XlvFCnsLk%3D (Pubitemid 44027735)
29. C Jobin CA Bradham MP Russo B Juma AS Narula DA Brenner RB Sartor 1999 Curcumin blocks cytokine-mediated nf-kappa b activation and proinflammatory gene expression by inhibiting inhibitory factor i-kappa b kinase activity J Immunol 163 6 3474 3483 10477620 1:CAS:528:DyaK1MXlvV2lt7o%3D (Pubitemid 29431852)
30. AL Kasinski Y Du SL Thomas J Zhao SY Sun FR Khuri CY Wang M Shoji A Sun JP Snyder D Liotta H Fu 2008 Inhibition of ikappab kinase-nuclear factor-kappab signaling pathway by 3, 5-bis(2-flurobenzylidene)piperidin-4-one (ef24), a novel monoketone analog of curcumin Mol Pharmacol 74 3 654 661 18577686 10.1124/mol.108.046201 1:CAS:528:DC%2BD1cXhtVClt7jJ
31. T Kawamori R Lubet VE Steele GJ Kelloff RB Kaskey CV Rao BS Reddy 1999 Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer Cancer Res 59 3 597 601 9973206 1:CAS:528:DyaK1MXhtV2rsbo%3D (Pubitemid 29076056)
32. AB Kunnumakkara P Anand BB Aggarwal 2008 Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins Cancer Lett 269 2 199 225 18479807 10.1016/j.canlet.2008.03.009 1:CAS:528:DC%2BD1cXhtFWlsrjM
33. CN Landen Jr MJ Birrer AK Sood 2008 Early events in the pathogenesis of epithelial ovarian cancer J Clin Oncol 26 6 995 1005 18195328 10.1200/JCO.2006.07.9970 (Pubitemid 351398093)
34. MH Lee BY Choi JK Kundu YK Shin HK Na YJ Surh 2009 Resveratrol suppresses growth of human ovarian cancer cells in culture and in a murine xenograft model: Eukaryotic elongation factor 1a2 as a potential target Cancer Res 69 18 7449 7458 19738051 10.1158/0008-5472.CAN-09-1266 1:CAS:528:DC%2BD1MXhtFaku7vE
35. J Leiro E Alvarez JA Arranz R Laguna E Uriarte F Orallo 2004 Effects of cis-resveratrol on inflammatory murine macrophages: Antioxidant activity and down-regulation of inflammatory genes J Leukoc Biol 75 6 1156 1165 14982945 10.1189/jlb.1103561 1:CAS:528:DC%2BD2cXkvVCit7Y%3D (Pubitemid 38720660)
36. YG Lin AB Kunnumakkara A Nair WM Merritt LY Han GN Armaiz-Pena AA Kamat WA Spannuth DM Gershenson SK Lutgendorf BB Aggarwal AK Sood 2007 Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappab pathway Clin Cancer Res 13 11 3423 3430 17545551 10.1158/1078-0432.CCR-06-3072 1:CAS:528:DC%2BD2sXmtVais78%3D (Pubitemid 46944931)
37. H Luo BH Jiang SM King YC Chen 2008 Inhibition of cell growth and vegf expression in ovarian cancer cells by flavonoids Nutr Cancer 60 6 800 809 19005980 10.1080/01635580802100851 1:CAS:528:DC%2BD1MXjvV2ntQ%3D%3D
38. SK Manna A Mukhopadhyay BB Aggarwal 2000 Resveratrol suppresses tnf-induced activation of nuclear transcription factors nf-kappa b, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation J Immunol 164 12 6509 6519 10843709 1:CAS:528: DC%2BD3cXktFWltbs%3D (Pubitemid 30408836)
39. P McGettigan D Henry 2006 Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2 Jama 296 13 1633 1644 16968831 10.1001/jama.296.13.jrv60011 1:CAS:528:DC%2BD28XhtVGjsrjL (Pubitemid 44511610)
40. M Mutoh M Takahashi K Fukuda Y Matsushima-Hibiya H Mutoh T Sugimura K Wakabayashi 2000 Suppression of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells by chemopreventive agents with a resorcin-type structure Carcinogenesis 21 5 959 963 10783318 10.1093/carcin/21.5.959 1:CAS:528:DC%2BD3cXjsFyht7s%3D (Pubitemid 30265140)
41. SK Myung W Ju HJ Choi SC Kim 2009 Soy intake and risk of endocrine-related gynaecological cancer: A meta-analysis Bjog 116 13 1697 1705 19775307
42. RB Ness C Cottreau 1999 Possible role of ovarian epithelial inflammation in ovarian cancer J Natl Cancer Inst 91 17 1459 1467 10469746 10.1093/jnci/91.17.1459 1:STN:280:DyaK1MvgtVyjuw%3D%3D (Pubitemid 29424550)
43. M Nihal N Ahmad H Mukhtar GS Wood 2005 Anti-proliferative and proapoptotic effects of (-)-epigallocatechin-3-gallate on human melanoma: possible implications for the chemoprevention of melanoma Int J Cancer 114 4 513 521 15609335 10.1002/ijc.20785 1:CAS:528:DC%2BD2MXisVWisrc%3D (Pubitemid 40349609)
44. G Ouyang L Yao K Ruan G Song Y Mao S Bao 2009 Genistein induces g2/m cell cycle arrest and apoptosis of human ovarian cancer cells via activation of DNA damage checkpoint pathways Cell Biol Int 33 12 1237 1244 19732843 10.1016/j.cellbi.2009.08.011 1:CAS:528:DC%2BD1MXhsVGltbbM
45. SY Park KJ Jeong J Lee DS Yoon WS Choi YK Kim JW Han YM Kim BK Kim HY Lee 2007 Hypoxia enhances lpa-induced hif-1alpha and vegf expression: their inhibition by resveratrol Cancer Lett 258 1 63 69 17919812 10.1016/j.canlet. 2007.08.011 1:CAS:528:DC%2BD2sXht1anu7zE (Pubitemid 47600493)
46. S Philip GC Kundu 2003 Osteopontin induces nuclear factor kappa b-mediated promatrix metalloproteinase-2 activation through i kappa b alpha/ikk signaling pathways, and curcumin (diferulolylmethane) down-regulates these pathways J Biol Chem 278 16 14487 14497 12473670 10.1074/jbc.M207309200 1:CAS:528:DC%2BD3sXjtVShtr8%3D (Pubitemid 36800002)
47. SM Plummer KA Holloway MM Manson RJ Munks A Kaptein S Farrow L Howells 1999 Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of nf-kappab activation via the nik/ikk signalling complex Oncogene 18 44 6013 6020 10557090 10.1038/sj.onc.1202980 1:CAS:528:DyaK1MXntlGitb8%3D (Pubitemid 29535013)
48. CV Rao A Rivenson B Simi BS Reddy 1995 Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound Cancer Res 55 2 259 266 7812955 1:CAS:528:DyaK2MXjtFyjs7Y%3D
49. SD Rao K Pagidas 2010 Epigallocatechin-3-gallate, a natural polyphenol, inhibits cell proliferation and induces apoptosis in human ovarian cancer cells Anticancer Res 30 7 2519 2523 20682977 1:CAS:528:DC%2BC3cXhtFWgtbnE
50. S Reuter S Eifes M Dicato BB Aggarwal M Diederich 2008 Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells Biochem Pharmacol 76 11 1340 1351 18755156 10.1016/j.bcp.2008.07.031 1:CAS:528:DC%2BD1cXhtl2qtLbM
51. YA Rezk SS Balulad RS Keller JA Bennett 2006 Use of resveratrol to improve the effectiveness of cisplatin and doxorubicin: Study in human gynecologic cancer cell lines and in rodent heart Am J Obstet Gynecol 194 5 e23 e26 16647892 10.1016/j.ajog.2005.11.030 1:CAS:528:DC%2BD28XktVGhtbY%3D
52. JM Schildkraut PG Moorman S Halabi B Calingaert JR Marks A Berchuck 2006 Analgesic drug use and risk of ovarian cancer Epidemiology 17 1 104 107 16357602 10.1097/01.ede.0000190538.55645.f8 Cambridge, Mass
53. JM Schildkraut PJ Schwingl E Bastos A Evanoff C Hughes 1996 Epithelial ovarian cancer risk among women with polycystic ovary syndrome Obstet Gynecol 88 4 Pt 1 554 559 8841217 10.1016/0029-7844(96)00226-8 1:STN:280: DyaK28vjvVyrsA%3D%3D (Pubitemid 26326017)
54. SS Seo YS Song DH Kang IA Park YJ Bang SB Kang HP Lee 2004 Expression of cyclooxygenase-2 in association with clinicopathological prognostic factors and molecular markers in epithelial ovarian cancer Gynecol Oncol 92 3 927 935 14984962 10.1016/j.ygyno.2003.11.055 1:CAS:528:DC%2BD2cXhsVOnsL8%3D (Pubitemid 38251398)
55. M Shakibaei T John G Schulze-Tanzil I Lehmann A Mobasheri 2007 Suppression of nf-kappab activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis Biochem Pharmacol 73 9 1434 1445 17291458 10.1016/j.bcp.2007.01.005 1:CAS:528:DC%2BD2sXjsVGitbs%3D (Pubitemid 46452591)
56. RA Sharma SA Euden SL Platton DN Cooke A Shafayat HR Hewitt TH Marczylo B Morgan D Hemingway SM Plummer M Pirmohamed AJ Gescher WP Steward 2004 Phase i clinical trial of oral curcumin: Biomarkers of systemic activity and compliance Clin Cancer Res 10 20 6847 6854 15501961 10.1158/1078-0432.CCR-04-0744 1:CAS:528:DC%2BD2cXpslGltLg%3D (Pubitemid 39383033)
57. S Singh BB Aggarwal 1995 Activation of transcription factor nf-kappa b is suppressed by curcumin (diferuloylmethane) [corrected] J Biol Chem 270 42 24995 25000 7559628 10.1074/jbc.270.42.24995 1:CAS:528:DyaK2MXovFWmsb8%3D
58. DR Siwak S Shishodia BB Aggarwal R Kurzrock 2005 Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of ikappab kinase and nuclear factor kappab activity and are independent of the b-raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the akt pathway Cancer 104 4 879 890 16007726 10.1002/cncr.21216 1:CAS:528:DC%2BD2MXhtVSltr3I (Pubitemid 41113691)
59. LA Solomon S Ali S Banerjee AR Munkarah RT Morris FH Sarkar 2008 Sensitization of ovarian cancer cells to cisplatin by genistein: The role of nf-kappab J Ovarian Res 1 1 9 19025644 10.1186/1757-2215-1-9
60. SD Solomon JJ McMurray MA Pfeffer J Wittes R Fowler P Finn WF Anderson A Zauber E Hawk M Bertagnolli 2005 Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention New Engl J Med 352 11 1071 1080 15713944 10.1056/NEJMoa050405 1:CAS:528:DC%2BD2MXit1Kqur4%3D (Pubitemid 40365348)
61. Subbaramaiah K, Michaluart P, Chung WJ, Tanabe T, Telang N, Dannenberg AJ (1999) Resveratrol inhibits cyclooxygenase-2 transcription in human mammary epithelial cells, vol 889. Annals of the New York Academy of Sciences, New York, pp 214-223
62. YJ Surh 2003 Cancer chemoprevention with dietary phytochemicals Nat Rev 3 10 768 780 10.1038/nrc1189 1:CAS:528:DC%2BD3sXotFChsLw%3D
63. X Tan N Sidell A Mancini RP Huang S Wang IR Horowitz DC Liotta RN Taylor F Wieser 2010 Multiple anticancer activities of ef24, a novel curcumin analog, on human ovarian carcinoma cells Reprod Sci 17 10 931 940 20693500 10.1177/1933719110374239 1:CAS:528:DC%2BC3cXht1GgsLfL
64. RL Thangapazham AK Singh A Sharma J Warren JP Gaddipati RK Maheshwari 2007 Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo Cancer Lett 245 1-2 232 241 16519995 10.1016/j.canlet.2006.01.027 1:CAS:528: DC%2BD2sXht1egsQ%3D%3D (Pubitemid 44959362)
65. SH Tsai SY Lin-Shiau JK Lin 1999 Suppression of nitric oxide synthase and the down-regulation of the activation of nfkappab in macrophages by resveratrol Bri J Pharmacol 126 3 673 680 10.1038/sj.bjp.0702357 1:CAS:528: DyaK1MXhslWit7w%3D (Pubitemid 29087846)
66. AS Whittemore R Harris J Itnyre 1992 Characteristics relating to ovarian cancer risk: collaborative analysis of 12 us case-control studies. Ii. Invasive epithelial ovarian cancers in white women. Collaborative ovarian cancer group Am J Epidemiol 136 10 1184 1203 1476141 1:STN:280:DyaK3s7hvVKgsQ%3D%3D (Pubitemid 23026890)
67. F Zhang NK Altorki JR Mestre K Subbaramaiah AJ Dannenberg 1999 Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells Carcinogenesis 20 3 445 451 10190560 10.1093/carcin/20.3.445 1:CAS:528:DyaK1MXhvFentr4%3D (Pubitemid 29112633)
68. M Zhang X Xie AH Lee CW Binns 2004 Soy and isoflavone intake are associated with reduced risk of ovarian cancer in southeast china Nutrit Cancer 49 2 125 130 10.1207/s15327914nc4902-2 1:CAS:528:DC%2BD2cXhtVentrnI (Pubitemid 39487870)